A

Armata Pharmaceuticals Inc
AMEX:ARMP

Watchlist Manager
Armata Pharmaceuticals Inc
AMEX:ARMP
Watchlist
Price: 6.0062 USD 1.8%
Market Cap: 218.2m USD

Relative Value

The Relative Value of one ARMP stock under the Base Case scenario is 2.8168 USD. Compared to the current market price of 6.0062 USD, Armata Pharmaceuticals Inc is Overvalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARMP Relative Value
Base Case
2.8168 USD
Overvaluation 53%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
26
vs Industry
39
Median 3Y
17.9
Median 5Y
25.8
Industry
7.9
Forward
39.5
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-3.5
Industry
23.7
Forward
-3.7
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.1
Industry
22
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.8
Industry
23.8
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
2.3
Industry
3.3
vs History
23
vs Industry
29
Median 3Y
21.9
Median 5Y
25.9
Industry
8.3
Forward
44.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-3.3
Industry
6.4
Forward
-7.6
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-3.3
Industry
7
Forward
-7.6
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.7
Industry
8.3
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-3.3
Industry
6.5
vs History
7
vs Industry
55
Median 3Y
1.5
Median 5Y
1.6
Industry
5.7

Multiples Across Competitors

ARMP Competitors Multiples
Armata Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Armata Pharmaceuticals Inc
AMEX:ARMP
213.5m USD 31.1 -8.5 -7.6 -7.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 809 907.8 -160 693.5 -195 133.1 -192 906.4
US
Abbvie Inc
NYSE:ABBV
400.4B USD 6.7 170.6 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
173.6B USD 4.8 24.7 17.9 17.9
US
Gilead Sciences Inc
NASDAQ:GILD
151.3B USD 5.2 18.7 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115B USD 9.8 31.3 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 083.7 -531.7 -579 -563.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.5B USD 5.6 17.4 16.5 18.8
AU
CSL Ltd
ASX:CSL
86.8B AUD 3.7 19.2 12.9 16.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.4 1 213.7 158 191.6
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.1 33.1 57.8 59.4
P/E Multiple
Earnings Growth PEG
US
A
Armata Pharmaceuticals Inc
AMEX:ARMP
Average P/E: 191.1
Negative Multiple: -8.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 693.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.7
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.7
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
9%
1.9
AU
CSL Ltd
ASX:CSL
19.2
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 213.7
N/A N/A
NL
argenx SE
XBRU:ARGX
33.1
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
A
Armata Pharmaceuticals Inc
AMEX:ARMP
Average EV/EBITDA: 39.4
Negative Multiple: -7.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 133.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.9
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
11%
1.5
AU
CSL Ltd
ASX:CSL
12.9
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
NL
argenx SE
XBRU:ARGX
57.8
839%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
A
Armata Pharmaceuticals Inc
AMEX:ARMP
Average EV/EBIT: 45.5
Negative Multiple: -7.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 906.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.9
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A
NL
argenx SE
XBRU:ARGX
59.4
N/A N/A